Blog - Litchlab

EN

CN

{$ImageUrl,alt}

Blog

Home>Blog

FBSH-EDC Hydrogel: An Innovative Material from Fetal Bovine Skin Tissue to Skin Repair

FBSH-EDC Hydrogel: An Innovative Material from Fetal Bovine Skin Tissue to Skin RepairIn the field of tissue engineering and regenerative medicine, naturally derived hydrogels have attracted significant attention due to their biocompatibility and soft structur...

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...

Colchicine Silk Fibroin Microneedles: Transdermal Therapy for Acute Gouty Arthritis – Litchlab Achieves Kilo-Scale Production and Full CDMO Support

With the growing demand for safer and more effective gout treatments, Litchlab has successfully developed colchicine-loaded silk fibroin microneedles, offering a novel transdermal delivery approach for acute gouty arthritis. This breakthrough not only addresse...

The New Era of Polysaccharide Microneedle Drug Delivery — litchlab Leads the Industrialization of Minimally Invasive Corneal Therapy Technology

With the growing demand for precision treatment of ophthalmic diseases, Polysaccharide Microneedle Systems (PSMNs) have emerged as a new class of minimally invasive drug delivery technologies, effectively overcoming the barriers of traditional ophthalmic formu...

Litchlab: Providing Kilogram-Scale DOTAP Liposomes and Complete Registration Support Services

Litchlab: Providing Kilogram-Scale DOTAP Liposomes and Complete Registration Support Services— From Raw Material Supply to Regulatory Filing, a One-Stop Professional SolutionWith the rapid development of nucleic acid drugs, gene therapy, and mRNA vaccines, the...

Advantages and Applications of DLin-MC3-DMA as a Pharmaceutical Excipient: Litchlab Offers Kilogram-Scale Production Solutions

With the rapid development of nucleic acid therapeutics and mRNA vaccines, lipid nanoparticles (LNPs) have become the most essential delivery platform for in vivo applications. Among them, DLin-MC3-DMA (commonly referred to as MC3) is the most representative i...

Conductive Hydrogel Breakthrough! PAM/PANI Enables Next-Generation “Smart” Wound Healing Solutions

With the increasing prevalence of chronic wounds, surgical incisions, and diabetic ulcers, wound dressings are no longer just about “coverage.” Modern medical needs are driving dressings toward intelligent, functional, and personalized solutions. Traditional w...

From Wound Care to Controlled Drug Release: PAM/CS Hydrogel Leading a New Wave in Medical Applications

As chronic wounds, diabetic ulcers, surgical incisions, and other wound types become increasingly complex, traditional dressings gradually reveal limitations in moisture retention, antibacterial properties, breathability, and bioactivity. To meet the modern de...

上一页 1 2 3 4 5 下一页